Contribution of Interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: A comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Ramos, José M ^a   Robledano, Catalina ^a   Masiá, Mar ^a   Belda, Sofia ^a   Padilla, Sergio ^a   Rodríguez, Juan C ^a   Gutierrez, Félix ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; ISONIAZID;

ADOLESCENT; ADULT; AGED; ARTICLE; BCG VACCINATION; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRISON; PROSPECTIVE STUDY; REFERENCE VALUE; SPAIN; TUBERCULIN TEST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPAIN; TUBERCULIN TEST; YOUNG ADULT;

EID: 84864325902     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-169     Document Type: Article

References (33)

1. Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H, . Swiss HIV Cohort Study Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007, 44:94-102. 10.1086/510080, 17143823, Swiss HIV Cohort Study.
2. American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005, 172:1169-1127. American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America.
3. Blumberg HM, Leonard MK, Jasmer RM. Update on the treatment of tuberculosis and latent tuberculosis infection. JAMA 2005, 293:2776-2784. 10.1001/jama.293.22.2776, 15941808.
4. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 1992, 268:504-509. 10.1001/jama.1992.03490040080029, 1619742.
5. Lalvani A, Pareek M. Interferon gamma release assays: principles and practice. EnfermInfeccMicrobiolClin 2010, 28:245-252.
6. Mazurek M, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, . IGRA Expert Committee; Centers for Disease Control and Prevention (CDC) Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010, 59(RR-5):1-25. IGRA Expert Committee; Centers for Disease Control and Prevention (CDC).
7. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 2006, 7:56. 10.1186/1465-9921-7-56, 1523341, 16579856.
8. Balcells ME, Pérez CM, Chanqueo L, Lasso M, Villanueva M, Espinoza M, Villarroel L, García P. A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int J Infect Dis 2008, 12:645-652. 10.1016/j.ijid.2008.03.005, 18534887.
9. Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, Sacks H. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis 2007, 11:1190-1195.
10. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007, 175:737-742. 10.1164/rccm.200608-1088OC, 1899289, 17218620.
11. Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, Mouton P, Diwakar L, Connell TG, Maartens G, Wilkinson RJ. Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007, 175:514-520.
12. Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, Oremek G, Rakus Z, Gottschalk R, Stark S, Brodt HR, Staszewski S. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 2008, 22:2471-2479. 10.1097/QAD.0b013e3283188415, 19005270.
13. Talati NJ, Seybold U, Humphrey B, Aina A, Tapia J, Weinfurter P, Albalak R, Blumberg HM. Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 2009, 9:15. 10.1186/1471-2334-9-15, 2649136, 19208218.
14. American Thoracic Society, Centers for Disease Control and Prevention Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Car Med 2000, 161:1376-1395. American Thoracic Society, Centers for Disease Control and Prevention.
15. Cellestis Limited. QuantiFERON-TB Gold Available at: http://www.cellestis.com. Accessed 20 February 2011.
16. Oxford Immunotec Limited. T-SPOT.TB Available at: http://www.oxfordimmunotec.com/T-SPOT_International. Accessed 20 February 2011.
17. User instructions. Microcapture Software Available at: http://videopen.narod.ru/usb-ustroistva/usb-mikroskop-200x-8-led/microcapture.pdf. Accessed 1 May 2012.
18. Food and Drug Administation T-SPOT-TB - PO70006 Available at: http://fda.gov/MedicalDEvices/ProductsandMedicalProcedures/DEciveApprovalsandClearances/PMAAAprovals/ucm102794.htm. Accessed 20 February 2011, Food and Drug Administation.
19. Landis JR, Koch GC. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174. 10.2307/2529310, 843571.
20. Mandalakas AM, Hesseling AC, Chegou NN, Kirchner HL, Zhu X, Marais BJ, Black GF, Beyers N, Walzl G. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008, 12:417-423.
21. Beffa P, Zellweger A, Janssens JP, Wrighton-Smith P, Zellweger JP. Indeterminate test results of T-SPOT.TB performed under routine field conditions. Eur Respir J 2008, 31:842-6. 10.1183/09031936.00117207, 18057053.
22. Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, Coleman C, Marston BJ, Huang L, Hopewell PC, Pai M. Interferon-Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in HIV-Infected Individuals: A Systematic Review and Meta-Analysis. J Acquir Immune Defic Syndr 2011, 56:230-238. 10.1097/QAI.0b013e31820b07ab, 3383328, 21239993.
23. Dheda K, Lalvani A, Miller RF, Scott G, Booth H, Johnson MA, Zumla A, Rook GA. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 2005, 19:2038-2041. 10.1097/01.aids.0000191923.08938.5b, 16260914.
24. Clark SA, Martin SL, Pozniak A, Steel A, Ward B, Dunning J, Henderson DC, Nelson M, Gazzard B, Kelleher P. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 2007, 150:238-244. 10.1111/j.1365-2249.2007.03477.x, 2219352, 17672869.
25. Sauzullo I, Mengoni F, Scrivo R, Valesini G, Potenza C, Skroza N, Marocco R, Lichtner M, Vullo V, Mastroianni CM. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. Int J Tuberc Lung Dis 2010, 14:834-840.
26. Markowitz N, Hansen NI, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Wilcosky TC, Wallace JM, Rosen MJ, Reichman LB, . The Pulmonary Complications of HIV Infection Study Group Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med 1997, 126:123-132. The Pulmonary Complications of HIV Infection Study Group.
27. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149:177-184. 2951987, 18593687.
28. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007, 146:340-354.
29. Leung CC, Yam WC, Yew WW, Ho PL, Tam CM, Law WS, Au KF, Tsui P. T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med 2010, 182:834-840. 10.1164/rccm.200912-1875OC, 20508217.
30. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011, 37:88-99. 10.1183/09031936.00115110, 21030451.
31. Aichelburg MC, Rieger A, Breitenecker F, Pfistershammer K, Tittes J, Eltz S, Aichelburg AC, Stingl G, Makristathis A, Kohrgruber N. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009, 48:954-962. 10.1086/597351, 19245343.
32. Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, Sarim C, Huffam S, Oelrichs R, Sophea P, Saphonn V, Kaldor J, Cooper DA, Chhi Vun M, French MA. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis 2009, 200:1736-1745. 10.1086/644784, 19874177.
33. Jonnalagadda S, Lohman Payne B, Brown E, Wamalwa D, Maleche Obimbo E, Majiwa M, Farquhar C, Otieno P, Mbori-Ngacha D, John-Stewart G. Latent tuberculosis detection by interferon γ release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children. J Infect Dis 2010, 202:1826-1825. 10.1086/657411, 3058232,3058232, 21067370.